Staff.unak.is
Improving services with informatics tools
Frank Sullivan and Jeremy C Wyatt
2005;331;1190-1192
Updated information and services can be found at:
These include:
This article cites 3 articles, 2 of which can be accessed free at:
One rapid response has been posted to this article, which you can access forfree at: You can respond to this article at:
Receive free email alerts when new articles cite this article - sign up in the
box at the top left of the article
A correction has been published for this article. The contents of the correctionhave been appended to the original article in this reprint. The correction is available online at:
To order reprints follow the "Request Permissions" link in the navigation box
ABC of health informatics
Improving services with informatics tools
Frank Sullivan, Jeremy C Wyatt
This article describes how many sources of data can be linked,
This is the 10th in a series of 12 articles
interpreted, and analysed before being presented to decision
A glossary of terms is available at http://
makers to improve care. It also discusses the legal issues
surrounding data protection and freedom of information.
A huge volume of data flows across the desk of a director of
public health (see box opposite). One of the director's problemsis to know which signals to act upon and what "noise" to ignore.
If the numbers being considered are small, as they probably willbe in the case described here, a critical incident analysis may be
You are a director of public health. The local paediatric
all that is needed. An individual prescriber, or group, may have
intensive care unit sends you a paper describing five
an erroneous belief or inadequate training. Critical incidents or
potentially avoidable admissions in the past two years—for
other signals often indicate that more data (such as data on
example, patients with severe asthma who were not being
prescribing steroids for paediatric asthma in primary care and
prescribed prophylactic drugs
outpatients) are needed.
Sources of data
Health services are awash with data. Earlier articles in the seriesdescribed the large and increasing numbers of sources of dataavailable to consumers, patients, clinicians, and administrators.
Clinicians, teams, divisions, and other groups collect the datathey need to carry out their work, and they may do so usingcoding and terms that others can understand and share. Theintensive care unit in this example integrated the data the teamneeds to manage patients during their stay with patients'pre-admission prescribing data. This local epidemiology mayhave been done as part of clinical governance activities, or as anad hoc exercise when a patient's problem was investigated.
One difficulty with secondary uses of clinical data is that,
having obtained the data indicating a problem exists, the issuemust be dealt with effectively. It may be that the individual orgroup who identify the problem have the knowledge, skills, andresources to resolve it. In other cases, such as these potentiallyavoidable asthma admissions, those responsible are not thosewho have uncovered the issue, and those potentially responsiblemay be unaware of the problem.
UK clinical governance definition*
Presentation of data
A framework through which NHS organisations are accountable forcontinually improving the quality of their services and safeguardinghigh standards of care by creating an environment in which
Ideally, the choice of measures, analysis, and presentation of
excellence in clinical care will flourish
data should be determined by the purpose of measurement andthe use to which data are to be put. This poses another difficulty
*From Scally G, Donaldson LJ. Clinical governance and the drive for quality
improvement in the new NHS in England. BMJ 1998;317:61-5
with the secondary use of clinical data. Studies have shown thatinterpretation of data is influenced by the method used tosummarise the results. Health policy makers, like doctors, tendto prefer measurements that report relative risks (or benefits) tomeasurements providing estimates of absolute risks (or
Categories of improvement for health services*
benefits). Once the decision has been taken to act on data, how
best to present the information should be considered.
x Patient centredness
Feedback of performance data
Different approaches (using internal or external influences on
*From Institute of Medicine Committee on Quality of Health Care in
decision makers) can be taken when using data to improve care.
America.Crossing the quality chasm: a new health system for the 21st century.
The interventions chosen should be tailored to the underlying
Washington, DC: National Academy Press, 2001
problem. At least two, and preferably three, of the moreeffective approaches (see boxes on next page) should be taken.
BMJ VOLUME 331 19 NOVEMBER 2005
Analysis of approaches to changing clinical practice: internal processes
Adult learning theories
Intrinsic motivation of
Bottom up, local consensus development
Small group interactive learningProblem based learning
Cognitive theories
Rational information seeking
Evidence based guideline development
and decision making
Disseminating research findings through
courses, mailing, journals
Health promotion, innovation
Attractive product adapted to
Needs assessment, adapting change
and social marketing theories
needs of target audience
proposals to local needs
Stepwise approachVarious channels for dissemination (mass
media and personal)
Analysis of approaches to changing clinical practice: external processes
Controlling performance by
Audit and feedback
Reminder systems, monitoringEconomic incentives, sanctions
Social interaction
Social learning and innovation
Social influence of important
Peer review in local networks
theories, social influence and
peers or role models
Outreach visits, individual instruction
Opinion leadersInfluencing key people in social networksPatient mediated interventions
Management theories, system
Creating structural and
Re-engineering care process
organisational conditions to
Total quality management and continuous
quality improvement approaches
Team buildingEnhancing leadershipChanging structures, tasks
Economic, power, and learning
Control and pressure, external
Regulations, laws
Budgeting, contractingLicensing, accreditationComplaints and legal procedures
Today, it is less necessary to rely on individual clinicians or
teams to produce routine reports because computerised dataentry enables the routine extraction of data for many purposes.
09 11 64 02 5 0
Data from multiple sources may be linked to records, and so
provide additional intelligence beyond the purposes for which
they were originally collected.
The community health index number (CHNo) is a unique 10 digit number
that includes the date of birth of individuals born, or moving to, Scotland so
that their encounters with the health service can be linked
Deterministic or probabilistic methods can be used with similarsuccess rates to link records. In the former case, a uniquepatient identifier, such as a 10 digit community health index
number, is applied to all personal health data—for example,
laboratory test requests and prescriptions. In the latter case,algorithms determine the likelihood that two items of databelong to the same person. The Soundex system converts aname to a code (for example, Michael becomes M240). The firstletter is the first letter of the word, and the numbers representphonetic parts of latter syllables. The algorithm determines that
John Smyth and John Smythe is the same child with asthma if
sufficient other characteristics (date of birth, street name) on the
admission data and community prescriptions match. Afterlinkage, each individual item of data may then be linked andanonymised for disease surveillance purposes.
The main provisions of the 1998 Data Protection Act wereimplemented on 1 March 2000. This act builds on the earlier
The community health index number (CHNo) allows the fragmented
1984 Data Protection Act. It is the means whereby the United
episodes of care experienced by individuals to be integrated into the
Kingdom enforces the 1995 European directive on data
completed jigsaw of an electronic health record
BMJ VOLUME 331 19 NOVEMBER 2005
protection. It aims to ensure that the processing (obtaining,
Principles of good practice in the 1998 Data Protection Act
recording, holding, doing calculations on) of information usingdata is done in accordance with the rights of individuals. The
Data are:
European directive also extends the legislation to manual, as
x Fairly and lawfully processed
x Processed for limited purposes
well as computerised, records containing personal information.
x Adequate, relevant, and not excessive
Under the provisions of the act, data controllers (for example,
general practitioners) are responsible for ensuring that access to
x Not kept longer than necessary
patient data should be under strictly controlled conditions and,
x Processed in accordance with the rights of the subject of the data
if necessary, with patients' consent.
Eight principles of good practice are in the act. Patients
x Not transferred to countries without adequate protection
should be aware, at least in broad terms, of the purposes forwhich their personal data are used. However, it is the view of thedata protection registrar that consent should normally be
Dame FIONA Caldicott's principles of data processing*
obtained when processing data about a patient's health. Many
x Formal justification of purpose
Caldicott guardians believe that the activities of the NHS are
x Information transferred only when absolutely necessary
often in the public interest, and in most cases the consent of the
x Only the minimum required
patient can be inferred. Other bodies, such as the General
x Need to know access controls
Medical Council and the BMA, advise that explicit consent is
x All to understand their responsibilities
x Comply with and understand the law
still preferable in some cases, and examples include:x
Release of details of patients to diabetic and cancer registers
Release of summaries of patient date to out of hours services.
The 2000 Freedom of Information Act came into force in
Approaches identified by the Nuffield Trust to deal with the
January 2005. It is intended to "promote a culture of openness
conflict between the the Freedom of Information Act and
and accountability amongst public sector bodies by providing
data protection legislation
people with rights of access to the information held by them." Itwill probably conflict with data protection legislation because
x Use personal data with consent or other assent from the subjects of
information about individuals is contextualised within families,
x Anonymise the data, then use them
communities, practices, and hospital units. It will be difficult to
x Use personal data without explicit consent, under a public interest
ensure that an individual's data are protected while giving
freedom of information to others within that context.
Feedback of information
Key issues in data feedback to improve quality*
x Data must be perceived by clinicians as valid to motivate change
In many medical cultures it is difficult to provide feedback that
x It takes time to develop the credibility of data
will be taken in a constructive manner. Certain principles make
x The source and timeliness of data are critical to perceived validity
it more likely that the feedback will be considered constructive
x Benchmarking improves the meaningfulness of data feedback
by recipients, and changes that could improve care will
x Opinion leaders can enhance the effectiveness of data feedback
probably be implemented.
x Data feedback that profiles an individual clinician's practices can be
effective but may be perceived as punitive
x Data feedback must persist to sustain improved performance
*Bradley EH, Holmboe ES, Mattera JA, Roumanis SA, Radford MJ, Krumholz
HM. Data feedback efforts in quality improvement: lessons learned from US
Confidentiality and security of data is probably a greater
hospitals. Qual Safety Health Care 2004;13:26-31
concern for researchers than clinicians, although clinicalresearchers need to live with concept of governance in bothworlds. Data collected for patient care may only be used to
produce research evidence with adequate safeguards for the
x Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR,
patients. Legislation varies between countries, but the highest
Vale L, et al. Effectiveness and efficiency of guideline dissemination
standards apply to use of personally identifiable data, where
and implementation strategies. Health Technol Assess 2004;8:1-72
x NHS Health Technology Assessment Programme. Effectiveness and
explicit signed, informed consent is often required. Some
efficiency of guideline dissemination and implementation
jurisdictions relax this standard if it is impossible, or extremely
strategies: www.ncchta.org/execsumm/summ806.htm (accessed 4
difficult, to obtain the consent. In other countries acceptable
anonymisation and adherence to rules of good epidemiological
x Fahey T, Griffiths S, Peters TJ. Evidence based purchasing:
practice allow the use of clinical data for research purposes.
understanding results of clinical trials and systematic reviews. BMJ1995;311:1056-9
x Lowrence WW. "Learning from experience." Privacy and the secondary
uses of data. London: The Nuffield Trust, 2002
x Berwick DM. Errors today and errors tomorrow. N Engl J Med
A public health consultant faced with complex, difficult choices,
such as the data on asthma prescribing, will prefer to discuss thereasons for apparent prescribing failures rather than taking
Frank Sullivan is NHS Tayside professor of research and development
pre-emptive action, which may do harm to the service overall.
in general practice and primary care, and Jeremy C Wyatt is professor
The factors that caused the presenting problem are often
of health informatics, University of Dundee.
rooted in the culture of the health system, and so the solution
The series will be published as a book by Blackwell Publishing in
often means changing the system. The consequences of failing
spring 2006.
to act when there is a problem need to be counterbalanced
Competing interests: None declared.
against the damage caused by incorrect interpretation of datacollected for one purpose but used for another.
BMJ VOLUME 331 19 NOVEMBER 2005
likely to be promoted may in part reflect this.
duced that have altered the career structures of hospi-
Investigating this point would require complete data
tal doctors. These include the Calman reforms,
on employment history since graduation. The data will
Modernising Medical Careers, further proposals for
also include doctors in the training grades who may
reform of the staff or associate specialist grades, and
not want to become a consultant, and the results may
new contracts for junior doctors and consultants. It is
be partly reflecting the preferences of this group, who
unclear what impact these changes will have on the
are more likely to be female and work part time. How-
issues discussed in this paper.
ever, this group is likely to be small.
Contributors: see bmj.com
Funding: The Health Economics Research Unit is funded by the
The achievement of current government targets for
Chief Scientist Office (CSO) of the Scottish Executive Health
the numbers of consultants are influenced by the pro-
Department. AS was funded through the Chief Scientist Office'score funding of the Health Economics Research Unit. KM was
motion process and the quality control exercised by
funded by the University of Aberdeen. The data were obtained for
the royal colleges. As the proportion of female doctors
research funded by the Scottish Executive Health Department on
increases, it will be difficult to meet government
NHS labour markets in Scotland. KM is guarantor.
targets unless the promotion process is re-examined.
Competing interests: None declared.
This should focus on the weight given to individuals'skills and ability and the flexibility of contracts and
Wooldridge JM. Econometric analysis of cross section and panel data. London,
working conditions. Safeguards will need to be in
England: MIT Press, 2002:453-509 (chapter 15).
Baltagi B. Econometric analysis of panel data. 2nd ed. Chichester: John
place to ensure that factors less likely to be related to
Wiley, 2001:11-27 (chapter 2).
ability or performance (such as sex, place of
Lambert TW, Goldacre MJ, Vallance E, Mallick N. Characteristics ofconsultants who hold distinction awards in England and Wales: database
graduation, or part time working) will not influence
analysis with particular reference to sex and ethnicity. BMJ 2004;328:1347.
promotion chances. Since 2000, when the data used in
(Accepted 16 September 2005)
this paper finish, several changes have been intro-
Corrections and clarifications
Achieving the millennium development goals for health: Cost
alter the conclusions of the paper. Also, in the
effectiveness analysis of strategies to combat malaria in
abstract,the figures in parentheses after the median
cotinine values are interquartile ranges not confidence
A mix-up during submission led to the wrong version
of table 3 being included in the full version of this
Primary care in the United States: problems and possibilities
paper (see bmj.com) by Chantal M Morel andcolleagues (BMJ 2005;331:1299-302, 3 Dec). The R
Electronic difficulties while handling the proofs led to
value for case management with chloroquine should
an error and an omission in this article by Robert L
be 0.35 (rather than 0.3). The adherence for
Phillips (BMJ 2005;331:1400-2,10 Dec). The author's
artemisinin based combination treatment should be
job title was wrong; he is in fact director of the Robert
35% (not 40%), and neither that nor the adherence for
Graham Center. In addition, the article should have
non-artemisinin based treatment needs a footnote.
contained the following disclaimer: "The information
Values for probability of success when patients were
and opinions contained in research from the Graham
not fully compliant should be 35% for non-artemisinin
Center do not necessarily reflect the views or policy of
based treatment and 0% for intermittent presumptive
the American Academy of Family Physicians."
treatment during pregnancy (rather than 35% and
Extra scrutiny for industry funded trials
10% respectively, as given). These revised values alsoapply to table B on bmj.com.
The title of this editorial by Kenneth J Rothman andStephen Evans (BMJ 2005;331:1350-1, 10 Dec) should
ABC of health informatics: Improving services with
have referred to "studies," not "trials." The authors
informatics tools
discussed all reports containing original data, so
The authors of this ABC article, Frank Sullivan and
"studies" would have been more accurate. The use of
Jeremy C Wyatt (BMJ 2005;331:1190-2, 19 Nov),
the word "trials" was the result of a late editorial
inadvertently omitted an acknowledgment from the
two tables at the top of p 1191 containing information
Treatment of bites by adders and exotic venomous snakes
on the analysis of approaches to changing clinicalpractice: internal and external processes. They were
In this Clinical Review by David A Warrell, the author's
first published by Grol R. BMJ 1997;315:418-21.
email address was wrong (BMJ 2005;331:1244-7, 26Nov). The correct address is
Legislation for smoke-free workplaces and health of bar
workers in Ireland: before and after study
Two errors occurred in this paper by Shane Allwright
Randomised placebo controlled multicentre trial to assess
and colleagues (BMJ 2005;331:1117-20, 12 Nov). The
short term clarithromycin for patients with stable coronary
model coefficients for cotinine concentrations in table
heart disease: CLARICOR trial
5 in the full version of this paper (see bmj.com) were
The main text and the summary box in this paper by
wrong because they had not been corrected to take
Christian M Jespersen and colleagues (BMJ
account of the conversion to SI units in table 6. The
2006;332:22-4, 7 Jan) refer to the patients in the trial
corrected table is at bmj.com (http://
being followed for up to three years. The authors have
clarified that the mean follow-up was 960 (range
1117/DC1). The authors state that the revisions do not
900-1070) days.
BMJ VOLUME 332 21 JANUARY 2006
Source: http://staff.unak.is/andy/HealthInfo0708/ABC/ABC10.pdf
SULLA TESTA.UN MONDO DA SCOPRIRE di Sujan Singh Non mi ero mai chiesto cosa spingesse diversi insegnanti, e non solo, ad indossare un turbante. Prima di avvicinarmi alla pratica dello Yoga pensavo si trattasse di un vezzo o di un segno distintivo, e non avevo mai sentito l'interesse ad osservare, oltre i limiti della mia superficialità, questo aspetto così particolare.fino a che non è stata la pratica stessa, spontaneamente, a suscitare in me un interesse sincero e quindi più profondo.
WORKING PARTIES ON LEUKAEMIA IN ADULTS AND CHILDREN TRIAL IN ACUTE MYELOID LEUKAEMIA OR HIGH RISK MYELODYS PLASTIC SYNDROME 17 PROTOCOL FOR PATIENTS AGED 18 to 60 (Trial Reference ISRCTN55675535) Through the use of a risk based approach AML17 will evaluate several relevant therapeutic questions in acute myeloid leukaemia (AML) as defined by WHO, and high risk Myelodysplastic Syndrome. The trial is open to all patients aged 18 to 60 years, and also to patients aged 60 years or over for whom intensive therapy is considered appropriate. At least 2800 patients will be recruited. For patients who do not have the Acute Promyelocytic Leukaemia (APL) subtype, an induction randomisation will compare two courses of the standard ADE with ADE or DA each in combination with one of two doses of the immunoconjugate Mylotarg in course 1 (five options). Consolidation will compare one course with two courses (MACE/Midac versus MACE).